Metabolic Disorders Therapeutics Market: Overview and Emerging Trends

Global Metabolic Disorders Therapeutics Market Size, Share & Trends Analysis Report By Disorder Type (Diabetes, Obesity, Hyperthyroidism, Hypercholesterolemia, Phenylketonuria (PKU), Lysosomal Storage Diseases (e.g., Gaucher disease, Fabry disease), Other Metabolic Disorders By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) – Forecast (2024-2032)

The Metabolic Disorders Therapeutics Market was USD 62.14 Billion in 2023 and is expected to grow USD 67.79 Billion in 2024. It is expected to continue growing at a CAGR of 9.1%, reaching USD 136.07 Billion by 2032.

List of Companies Profiled

 

  • Novo Nordisk A/S
  • Sanofi S.A.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca
  • Amgen Inc.
  • Takeda Pharmaceutical Company Limited
  • Biogen Inc.
  • Johnson & Johnson

Report Scope and Segmentations

Study Period 2024-32
Base Year 2023
Estimated Forecast Year 2024-32
Growth Rate CAGR of 9.1% from 2024 to 2032
Segmentation By Disorder Type, By Drug Class, By Route of Administration, By Treatment Type, By End User, By Distribution Channel, By Region
Unit USD Billion
By Disorder Type
  • Diabetes
  • Obesity
  • Hyperthyroidism
  • Hypercholesterolemia
  • Phenylketonuria (PKU)
  • Lysosomal Storage Diseases (e.g., Gaucher disease, Fabry disease)
  • Other Metabolic Disorders (e.g., galactosemia, urea cycle disorders)
By Drug Class
  • Insulin
  • Enzyme Replacement Therapy (ERT)
  • Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
  • Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors
  • Statins
  • Other Drug Classes
By Route of Administration
  • Oral
  • Injectable
  • Others (e.g., topical, nasal)
By Treatment Type
  • Gene Therapy
  • Cellular Therapy
  • Pharmacological Therapy
  • Lifestyle Modifications (diet, exercise, etc.)
  • Combination Therapy
By End User
  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Research Institutes
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • MEA (Saudi Arabia, South Africa, UAE, Rest Of MEA)

About US:

IMIR® Market Research Pvt Ltd.

Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

IMIR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn

Mr. Smit Patel

Phone: +1 (814) 487 8486

Email: smit@intellectualmarketinsights.com

Corporate Sales: sales@intellectualmarketinsights.com

Leave a Reply

Your email address will not be published. Required fields are marked *

About Us | Privacy Policy | Editorial Policy | Disclaimer | Terms and Conditions | Report A Problem | Contact Us